|[January 02, 2014]
Foundation Medicine to Present at the 32nd Annual J.P. Morgan Healthcare Conference
CAMBRIDGE, Mass. --(Business Wire)--
Medicine today announced that Michael J. Pellini, M.D., president
and chief executive officer, is scheduled to present at the 32nd
Annual J.P. Morgan Healthcare Conference on Wednesday, January 15, 2014
at 8:00 a.m. PST in San Francisco.
A live, listen-only webcast of the presentation can be accessed by
visiting the investors section of the Foundation Medicine website at
investors.foundationmedicine.com. A replay of the webcast will be
available shortly after the conclusion of the presentation and archived
on the company's website for two weeks following the presentation.
About Foundation Medicine
Medicine® (NASDAQ:FMI) is a molecular information company
dedicated to a transformation in cancer care in which treatment is
informed by a deep understanding of the genomic changes that contribute
to each patient's unique cancer. The company's clinical assays, FoundationOneTM
for solid tumors and FoundationOneTM
Heme for hematologic malignancies, sarcomas and pediatric cancers, each
provide a fully informative genomic profile to identify a patient's
individual molecular alterations and match them with relevant targeted
therapies and clinical trials. Foundation Medicine's molecular
information platform aims to improve day-to-day care for patients by
serving the needs of clinicians, academic researchers and drug
developers to help advance the science of molecular medicine in cancer.
For more information, please visit www.FoundationMedicine.com
or follow Foundation Medicine on Twitter
Foundation Medicine® is a registered trademark, and FoundationOneTM
is a trademark, of Foundation Medicine, Inc.
[ Back To Technology News's Homepage ]